The effect of botulinum toxin type A injection into the gastrocnemius muscle on sit-to-stand transfer in children with spastic diplegic cerebral palsy

Clinical Rehabilitation

Volumn 20, Issue 8, 2006, Pages 668-674

  Park, Eun Sook ^a   Park II, Chang ^a   Chang, Hyun Chung ^a   Park, Chan Woo ^a   Lee, Don Shin ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ANALYZER; ANKLE; ARTICLE; CASE CONTROL STUDY; CEREBRAL PALSY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GASTROCNEMIUS MUSCLE; HIP; HOSPITAL PATIENT; HUMAN; INJECTION; KINEMATICS; KNEE; PARALYSIS; PATIENT TRANSPORT; PELVIS; PRESCHOOL CHILD; RANGE OF MOTION; SITTING; SPASTICITY; STANDING; UNIVERSITY HOSPITAL;

ANKLE; BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS, TYPE A; CASE-CONTROL STUDIES; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; HUMANS; INJECTIONS, INTRAMUSCULAR; MUSCLE SPASTICITY; MUSCLE, SKELETAL; NEUROMUSCULAR AGENTS;

EID: 33748088503     PISSN: 02692155     EISSN: None     Source Type: Journal    
DOI: 10.1191/0269215506cre985oa     Document Type: Article

References (24)

1. Riley PO, Schneckman ML, Mamm RW, Hodge RW, Hodge WA. Mechanics of a constrained chair-rise. J Biomech 1991; 24: 77-85.
2. Su FC, Lai KA, Hong WH. Rising from chair after total knee arthroplasty. Clin Biochem 1998; 13: 176-81.
3. Bahrami F, Reiner R, Jabedar-Maralani P, Schmidt G. Biomechanical analysis of sit-to-stand transfer in healthy and paraplegic subjects. Clin Biomech 2000; 15: 123-33.
4. Hennington G, Johnson J, Penrose J, Barr K, McMulkin ML, Vander Linden DW. Effect of bench height on sit-to-stand in children without diabilities and children with cerebral palsy. Arch Phys Med Rehabil 2004; 85: 70-76.
5. Wilson H, Harideri N, Song K. Telford D. Ankle-foot orthoses for preambulatory children with spastic diplegia. J Pediatr Orthop 1977; 17: 370-76.
6. Park ES, Park CI, Lee HJ, Kim DY, Lee DS, Cho SR. The characteristics of sit-to-stand transfer in young children with spastic cerebral palsy based on kinematic and kinetic data. Gait Posture 2003; 17: 43-49.
7. Cheng PT, Chen CL, Wang CM, Hong WH. Leg muscle activation patterns of sit-to-stand movement in stroke patients. Am J Phys Med Rehabil 2004; 83: 10-16.
8. Cosgrove AP, Corry IS, Graham HK. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1993; 36: 386-96.
9. Koman LA, Mooney JF, Smith BP, Goodman A, Mulvaney T. Management of spasticity in cerebral palsy with botulinum toxin A: preliminary investigation. J Pediatr Orthop 1993; 13: 489-95.
10. Koman LA, Mooney JF, Mulvaney T, Roberts S, Smith BP. Further evaluation of botulinum toxin (Botox) in the management of cerebral palsy. Dev Med Child Neurol 1993; 35: 29-30.
11. Koman LA Mooney JF, III, Smith BP, Goodman A, Mulvaney T. Management of spasticity in cerebral palsy with botulinum A toxin: report of a preliminary, randomized, double blind trial. J Pediatr Orthop 1994; 14: 299-303.
12. Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG. Injection of botulinum A toxin into the gastrocnemius muscle of patients with cerebral palsy; a 3-dimensional motion analysis study. Gait Posture 1996; 4: 269-79.
13. Thompson NS, Cosgrove IS, Graham HK. Musculoskeletal modeling in determining the effect of botulinum toxin on the hamstring of patients with crouch gait. Dev Med Child Neurol 1998; 40: 622-25.
14. Ubhi T, Bhakta BB, Ives HL, Allgar V, Roussounits SH. Randomized double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child 2000; 83: 481-87.
15. Bohannon RW, Smith MB, Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206-207.
16. Lee MY, Wong MK, Tang FT, Cheng PT, Lin PS. Comparison of balance responses and motor patterns during sit-to-stand task with functional mobility in stroke patients. Am J Phys Med Rehabil 1997; 76: 401-10.
17. Chou WS, Wong AMK, Leong CP, Hong WS, Tang FT, Lin TH. Postural control during sit-to-stand and gait in stroke patients. Am J Phys Med Rehabil 2003; 82: 42-47.
18. Hesse S, Brandl-Hesse B, Seidel U, Doll B, Gregoric M. Lower limb muscle activity in ambulatory children with cerebral palsy before and after the treatment with botulinum toxin A. Restor Neurol Neurosci 2000; 17: 1-8.
19. Hesse S, Kranjnik K, Luecke D, Jahnke MT, Gregoric M, Mauritz KH. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. Stroke 1996; 27: 455-60.
20. Butler PB, Nene AV, Major RE. Biomechanics of transfer from sitting to the standing position in some neuromuscular diseases. Physiotherapy 1991; 77: 521-25.
21. Schultz AB, Alexander NB, Ashton-Miller JA. Biomechanical analysis of rising from a chair. J Biomech 1992; 25: 1383-91.
22. Doorenbosch CAM, Harlaar J, Roebroeck ME, Lankhorst GJ. Two strategies of transferring from sit-to-stand; the activation of monoarticular and biarticular muscles. J Biomech 1994; 27: 1299-307.
23. Pai YC, Rogers MW. Speed variation and resultant joint torques during sit-to-stand. Arch Phys Med Rehabil 1991; 72: 881-85.
24. Mark MK, Hui-Chan CW. The speed of sit-to-stand can be modulated in Parkinson's disease. Clin Neurophysiol 2005; 116: 780-89.